Trial intelligence / Profile preview

Dexmedetomidine and fundus hemodynamics during general anesthesia

ChiCTR2400092155Phase 4Recruiting

Sponsor
Hebei Eye Hospital
Start
Nov 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of dexmedetomidine (4 arms), sponsored by Hebei Eye Hospital. Primary endpoints: Peak systolic velocity, End-diastolic velocity and 2 more. Started Nov 2024; status: recruiting.

02

Drugs

dexmedetomidine

Beyond the preview

Go deeper on ChiCTR2400092155.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400092155.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call